Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
84.1M
-
Shares change
-
+16.3M
-
Total reported value, excl. options
-
$5.8B
-
Value change
-
+$1.14B
-
Put/Call ratio
-
0.46
-
Number of buys
-
107
-
Number of sells
-
-78
-
Price
-
$69.03
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q2 2023
221 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q2 2023.
Legend Biotech Corp - COMMON STOCK (LEGN) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.1M shares
of 367M outstanding shares and own 22.88% of the company stock.
Largest 10 shareholders include FMR LLC (17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.03M shares), HHLR ADVISORS, LTD. (6.44M shares), RA CAPITAL MANAGEMENT, L.P. (6.26M shares), BlackRock Inc. (4.74M shares), Capital World Investors (2.39M shares), FEDERATED HERMES, INC. (1.94M shares), Polar Capital Holdings Plc (1.87M shares), Capital International Investors (1.86M shares), and JANUS HENDERSON GROUP PLC (1.81M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.